Enterprise Value
-41.56M
Cash
126.4M
Avg Qtr Burn
-18.9M
Short % of Float
4.98%
Insider Ownership
6.52%
Institutional Own.
57.40%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
BDC-1001 Details HER2-expressing cancers | Phase 2 Initiation |